Influenza Vaccination

Resource Center

Slideshows

Research Summaries

Video

Video

PUPC Recap—Up to Date: What's New in Immunizations for Primary Care in 2026

08/20/2026

William Schaffner, MD

Dr. William Schaffner, MD, reviews evolving adult vaccination guidance and key opportunities to prevent severe disease in clinical practice.

08/20/2026

FDA Approval

FDA Approval

FDA Approves mFLUSIVA for Influenza Prevention in Adults Aged 50 Years and Older

08/07/2026

Anthony Calabro, MA

The FDA approved an mRNA-based influenza vaccine mFLUSIVA for adults aged 50 years and older, with accelerated approval applying to adults aged 65 years and older.

08/07/2026

Respiratory Diseases Roundup

Respiratory Diseases Roundup

New Influenza and RSV Research Highlights Vaccine Effectiveness and Hospitalization Prevention

08/04/2026

Ashton L. Stahl

New influenza and RSV research offers clinically relevant insights into vaccine performance and outbreak prevention. This roundup examines an investigational mRNA flu vaccine, rapid oseltamivir use in...

08/04/2026

Respiratory Diseases Roundup

Respiratory Diseases Roundup

New Data on Long COVID, Vaccine Effectiveness, Kidney Risk, Household Transmission, and Influenza Vaccine Coadministration

07/14/2026

Ashton L. Stahl

Recent studies address Long COVID surveillance, household transmission, updated vaccine effectiveness, kidney outcomes, and influenza vaccine coadministration.

07/14/2026

Clinical Guidance

Clinical Guidance

ACOG Releases 2026 Maternal Immunization Schedule

06/11/2026

Anthony Calabro, MA

ACOG’s 2026 maternal immunization schedule outlines vaccine recommendations before, during, and after pregnancy, including influenza, COVID-19, Tdap, and RSV vaccination.

06/11/2026

August 2026

Current Issue

August 2026